Company Data
StageZero Life Sciences Ltd
Ticker
SZLSF
Current Price
$0.02 1076.47%
Market Cap
$2.5M
Price Target
Refer to Report
Volume
1.1K
52wk Range
$0.0015 - $0.9999
Overview
StageZero Life Sciences Ltd is a Canadian company, focused on developing and commercializing proprietary molecular diagnostic tests for early detection of diseases and personalized health management, with a primary focus on cancer-related indications. It develops a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. Its lead product, ColonSentry is a blood test to determine the patient’s current risk of having colorectal cancer.